Key Financial Inc’s GSK GSK Stock Holding History

Key Financial Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.4K	Sell	560 -84	-13%	-$4.44K	﹤0.01%	651
2026 Q1	$35.5K	Buy	644 +46	+8%	+$2.49K	0.01%	607
2025 Q4	$29.3K	Hold	598	–	–	0.01%	642
2025 Q3	$27.2K	Buy	598 +38	+7%	+$1.48K	0.01%	645
2025 Q2	$21.5K	Buy	+560	New	+$21.4K	﹤0.01%	677
2022 Q3	–	Sell	-861	Closed	-$47K	–	1140
2022 Q2	$47K	Hold	861	–	–	0.03%	368
2022 Q1	$47K	Hold	861	–	–	0.02%	370
2021 Q4	$47K	Hold	861	–	–	0.02%	356
2021 Q3	$41K	Buy	861 +197	+30%	+$9.89K	0.02%	365
2021 Q2	$33K	Hold	664	–	–	0.02%	401
2021 Q1	$30K	Hold	664	–	–	0.02%	344
2020 Q4	$31K	Buy	+664	New	+$30.5K	0.02%	315
2020 Q2	–	Sell	-753	Closed	-$35K	–	309
2020 Q1	$35K	Buy	+753	New	+$40.2K	0.04%	258

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Key Financial Inc's GSK Position: Q2 2026 in Review

Key Financial Inc reduced its GSK (GSK) stake by 13% in Q2 2026, selling an estimated $4.44K and leaving 560 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

Key Financial Inc first reported a position in GSK in Q1 2020 and has held it in 13 quarters since. The position peaked at $47K in Q2 2022. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Key Financial Inc held 560 shares of GSK worth $29.4K as of Q2 2026.
Key Financial Inc sold 84 GSK shares in Q2 2026, an estimated $4.44K.
GSK made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #651 holding.
Key Financial Inc first reported a position in GSK in Q1 2020 and has held it in 13 quarters since.
Key Financial Inc's GSK position peaked at $47K in Q2 2022.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.